BlackRock »

Taysha Gene Therapies shares owned by BlackRock

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Taysha Gene Therapies

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 2924M25M26M27M13.52M13.525M13.53M
Value ($)Share countHistorical TSHA position of BlackRock Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by BlackRock

Quarter filed Position value Share count Share price at filing
2024-12-31 $23M 14M 1.73
2024-09-30 $27M 14M 2.01

More positions owned by BlackRock

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Mastercard Incorporated Cl A (MA)

View all positions for BlackRock

Top funds holding Taysha Gene Therapies

venBio Select Advisor
Morgan Stanley
FMR
BlackRock
RA Capital Management
Octagon Capital Advisors
Vanguard Group
Rtw Investments
Siren
State Street Corporation
Adage Capital Partners GP
Baker Bros. Advisors
Tybourne Capital Management
Geode Capital Management
VR Adviser

View all funds holding Taysha Gene Therapies